KOL Knockout™ — Cataract Edition: Surgeons Battling for the Best Outcomes

KOL Knockout  Cataract Edition Surgeons Battling for the Best Outcomes
Details
Download PDF
  • Overview

    This continuing medical education (CME) activity captures content from a three live virtual symposia.

    ACTIVITY DESCRIPTION
    This supplement summarizes content from a series of three unique, live virtual symposia hosted by Uday Devgan, MD, FACS, FRCS. The game show-style quiz competition with real-time audience voting featured cataract-focused case studies and discussions regarding patient care and surgical approaches among seven key opinion leaders/contestants. The archived video series can be viewed here: https://evolvemeded.com/course-group/kol-knockoutcataract-edition-aberrometry-femtosecond-lasers-advanced-iols.

    TARGET AUDIENCE
    This certified CME activity is designed for ophthalmologists.

    This activity is supported by an unrestricted educational grant from Alcon Vision.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Summarize the technology of femtosecond laser-assisted cataract surgery.
    • Explain how to incorporate femtosecond laser technology into cataract surgery techniques.
    • Establish when to incorporate intraoperative aberrometry to provide better refractive outcomes for cataract patients.
    • Evaluate patient lifestyles and expectations to improve intraocular lens choice.
    • Compare current and emerging technologies in advanced technology intraocular lenses

    • Accreditation

      Provided by 

      Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      CREDIT DESIGNATION STATEMENT
      Evolve Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Uday Devgan, MD, FACS, FRCS

      Uday Devgan, MD, FACS, FRCS

      Program Chair
      Private Practice
      Devgan Eye Surgery
      Partner, Specialty Surgical Center
      Chief of Ophthalmology
      Olive View UCLA Medical Center

      Los Angeles, California


      Ravi D. Goel, MD

      Ravi D. Goel, MD

      Comprehensive Ophthalmologist
      Regional Eye Associates
      Cherry Hill, NJ
      Instructor
      Wills Eye Hospital
      Philadelphia, PA


      David A. Goldman, MD

      David A. Goldman, MD

      Private practice
      Goldman Eye

      Palm Beach Gardens, Florida


      Himani Goyal, MD

      Himani Goyal, MD

      Assistant Clinical Professor
      Cataract, Cornea, & Refractive Surgery
      NYU Langone Eye Center


      John A. Hovanesian, MD

      John A. Hovanesian, MD

      Clinical Instructor
      Jules Stein Eye Institute
      University of California Los Angeles
      Owner
      Harvard Eye Associates
      Laguna Hills, California


      Robert F. Melendez, MD, MBA

      Robert F. Melendez, MD, MBA

      Founder and CEO
      Juliette Eye Institute
      Clinical Associate Professor
      University of New Mexico
      Albuquerque, New Mexico


      Zaina Al-Mohtaseb, MD

      Zaina Al-Mohtaseb, MD

      Associate Professor of Ophthalmology
      Associate Residency Program Director, Cornea, Cataract, and Refractive Surgery
      Baylor College of Medicine
      Houston, Texas


      Denise M. Visco, MD, MBA

      Denise M. Visco, MD, MBA

      Medical Director and Founder
      Eyes of York
      York, Pennsylvania


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Uday Devgan, MD, FACS, FRCS, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker: Bausch & Lomb and Novartis; Shareholder: Advanced Euclidean Solutions, CataractCoach.com, and LensGen.

      Ravi D. Goel, MD, has had no financial agreement or affiliation during the past year.

      David A. Goldman, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, and Novartis. Speaker's Bureau: Allergan, and Eyevance. Stock/Shareholder: Alcon, Allergan, Johnson & Johnson, Kala Pharmaceuticals, Ocular Therapeutix, Stroma, and Tarsus.

      Himani Goyal, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Carl Zeiss Meditec. Grant/Research Support: Research to Prevent Blindness.

      John A. Hovanesian, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Advisory Board: 1-800-Doctors, Aerie Pharmaceuticals, Abbott Medical Optics, Blephex, Cord, Eyedetec, Glaukos, Guardian Health Sciences, Ingenoeye, IOP/Katena, Ivantis, Kala, MDBackline, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Sight Sciences, Tearlab,  Tearfilm Innovations, Valeant, and Veracity. Consultant:  1-800-Doctors, Acufocus, Aerie Pharmaceuticals, Alcon Vision, Allegro Ophthalmics, Allergan, Abbott Medical Optics, BlephEx,  Eyedetec, Glaukos, Guardian Health Sciences, IOP/Katena, Ivantis, Kala, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Sarentis ophthalmics, Sensimed, Shire, Tearlab, Tearfilm Innovations, Valeant, and Veracity. Grant/Research: Aerie Pharmaceuticals, Abbott Medical Optics, Alcon Vision, Allergan, Cloudbreak Therapeutics, Cord, Eydetec, Glaukos, Ingenoeye, IOP/Katena, Novartis, Ocular Therapeutix, Omeros, ReVision Optics, Shire, Tearfilm Innovations, and Valeant. Stock/Shareholder/Equity: Alcon Vision, Alicia Surgery Center, Allegro Ophthalmics, Allergan, BlephEx, Eyedetec, Glaukos, Guardian Health Sciences, Harvard Eye Associates, Harvard Hearing, Ingenoeye, MDBackline, Novartis, Ocular Therapeutix, RxSight, Sarentis Ophthalmics, Sight Sciences, and Tearfilm Innovations. Royalties: SlackBooks and TLC: The Laser Center.

      Robert F. Melendez, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker: Alcon Vision.

      Zaina Al-Mohtaseb, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Bausch + Lomb, Carl Zeiss Meditec, Corneagen, and Ocular Therapeutix.

      Denise M. Visco, MD, MBA, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bruder, Carl Ziess Meditec, Cassini, Lensar, Omeros, and Sun Pharmaceutical Industries. Grant/Research Support: Carl Ziess Meditec, Lensar, Omeros, Oyster Point Pharma, and Sun Pharmaceutical Industries. Speaker’s Bureau: Carl Ziess Meditec, Lensar, Omeros, and Sun Pharmaceutical Industries. Stock/Shareholder: Eyevance.

      The Evolve staff and planners have no financial relationships with commercial interests. Michelle Dalton, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract and Refractive Surgery Today, MillennialEYE, or Alcon Vision.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    1.50 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free